Brief: IN8BIO Updated Data From Phase 1 Investigator-Sponsored Trial Of INB-100

IN8bio

11/12/2023 14:16

Dec 11 (Reuters) - IN8BIO, Inc.  INAB.O :
    * IN8BIO, INC. - UPDATED DATA FROM PHASE 1
INVESTIGATOR-SPONSORED
TRIAL OF INB-100
    * IN8BIO, INC. - 100% OF EVALUABLE TREATED PATIENTS (N=10)
REMAIN
ALIVE, PROGRESSION FREE, AND IN DURABLE COMPLETE REMISSION (CR)
AS OF NOV 3

Source text for Eikon: [https://bitly.ws/35pLd]
Further company coverage:  INAB.O 

 ((Reuters.Briefs@thomsonreuters.com;))